SCHEMBL5111593

SCHEMBL5111593

CC(C)C(=O)Nc1cc(COc2c(Br)cc(C(=O)NCC(=O)O)cc2Br)cc(C(F)(F)F)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
THRA P10827 2/20 0.42
THRB P10828 2/20 0.42
SENP5 Q96HI0 1/20 0.38
SENP2 Q9HC62 1/20 0.38
SENP1 Q9P0U3 1/20 0.38
ALDH1A1 P00352 1/20 0.38
RHOC P08134 1/20 0.38
RHOA P61586 1/20 0.38
SCN9A Q15858 2/20 0.38
CLPP Q16740 1/20 0.37
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
MME P08473 1/20 0.36
ACE P12821 1/20 0.36
CPA1 P15085 1/20 0.36
ACE2 Q9BYF1 1/20 0.36
HTT P42858 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
DHODH Q02127 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5118577 0.91 SCN9A (0.41) SENP5SENP2SENP1ALDH1A1RHOC
SCHEMBL4934248 0.89 THRA (0.44) THRATHRBALDH1A1RHOCRHOA
SCHEMBL5117735 0.89 THRA (0.44) THRATHRBSENP5SENP2SENP1
SCHEMBL5106633 0.88 RHOC (0.43) THRATHRBSENP5SENP2SENP1
SCHEMBL5111314 0.87 SENP5 (0.40) THRATHRBSENP5SENP2SENP1
SCHEMBL4924564 0.87 THRA (0.45) THRATHRBSENP5SENP2SENP1
SCHEMBL5722472 0.87 THRB (0.41) THRATHRBSENP5SENP2SENP1
SCHEMBL5110890 0.86 SENP5 (0.40) THRATHRBSENP5SENP2SENP1
SCHEMBL5110065 0.86 SENP5 (0.40) THRATHRBSENP5SENP2SENP1
SCHEMBL4931455 0.86 THRA (0.41) THRATHRBALDH1A1RHOCRHOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080004251-A1 Novel Pharmaceutical Compositions Comprising Agonists of the Thyroid Receptor KARO BIO AB (SE) 2008-01-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080004251-A1 Novel Pharmaceutical Compositions Comprising Agonists of the Thyroid Receptor TSHR, TRHR, THRA THRA 3/4885THRB 4/4885SENP5 2379/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.